Scott Morenstein is a Managing Director in Blackstone Multi-Asset Investing (BXMA).

Before joining Blackstone in 2022, Mr. Morenstein previously served as Managing Director at CAM Capital, where he led biotechnology investing since November 2013. Prior to joining CAM Capital, Mr. Morenstein served as managing director at Valence Advantage Life Sciences Fund from January 2012 to November 2013. Prior to Valence Advantage Life Sciences Fund, he served as principal at Caxton Advantage Venture Partners from 2007 until 2011. Prior to that, he served as an investment banking associate and founding member of Seaview Securities from 2003 to 2005. Mr. Morenstein began his career at Lehman Brothers as a healthcare investment banker and equity research analyst, where he worked from 2000 to 2002. 

Mr. Morenstein holds an M.B.A. from Harvard Business School and a B.A. from the University of Pennsylvania with a degree in the Biological Basis of Behavior.